Format

Send to

Choose Destination
Am J Health Syst Pharm. 2017 Mar 1;74(5):325-348. doi: 10.2146/ajhp160919. Epub 2017 Jan 4.

ASHP Guidelines on Preventing Diversion of Controlled Substances.

Author information

1
Froedtert & The Medical College of Wisconsin, Milwaukee, WI.
2
ASHP, Bethesda, MD.
3
Brigham and Women's Healthcare, Boston, MA.
4
University of Michigan Hospitals and Health Centers, Ann Arbor, MI.
5
Mayo Clinic, Rochester, MN.
6
BD Dispensing Technologies & Solutions, San Diego, CA.
7
The Resource Group (Ascension), St. Louis, MO.
8
Carnegie, PA.
9
Massachusetts General Hospital, Boston, MA.
10
Abbott Northwestern Hospital, Allina Health, Minneapolis, MN.
11
University of Wisconsin Health, Madison, WI.
12
University of Michigan Hospitals and Health Centers, University of Michigan College of Pharmacy, Ann Arbor, MI.
13
Banner Pharmacy Services, Phoenix, AZ.
14
Rhode Island and Hasbro Children's Hospital, Providence, RI.
15
Baylor Scott and White Medical Center, Temple, TX.
16
Cardinal Health Innovative Delivery Solutions, Knoxville, TN.
17
Children's Mercy Hospital, Kansas City, MO.
18
Children's Mercy Kansas City, Kansas City, MO.
19
University of Virginia Health System, Charlottesville, VA.
20
The Johns Hopkins Health System, Baltimore, MD.

KEYWORDS:

controlled substances; documentation; facility regulation and control; patient safety; prescription drug diversion; quality improvement

PMID:
28052859
DOI:
10.2146/ajhp160919
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center